Profilo
Hilary Webber is currently the Chairman at Eqalis Pharmaceuticals Ltd.
Previously, Ms. Webber worked as an Independent Non-Executive Director at Cannasouth Ltd.
Posizioni attive di Hilary Webber
| Società | Posizione | Inizio |
|---|---|---|
Eqalis Pharmaceuticals Ltd
 Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Presidente | - |
Precedenti posizioni note di Hilary Webber
| Società | Posizione | Fine |
|---|---|---|
| CANNASOUTH LIMITED | Direttore/Membro del Consiglio | 01/01/2024 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CANNASOUTH LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Eqalis Pharmaceuticals Ltd
Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |
- Borsa valori
- Insiders
- Hilary Webber
